N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
US9512111B2 · kind B2 · utility
21Cited by
25References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 8, 2011 |
| Grant date | Dec 6, 2016 |
| Priority date | — |
| Expiry date | Aug 2, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides tetrahydroquinoline and related compounds, pharmaceutical compositions, methods of inhibiting RORγ activity, reducing the amount of IL-17 in a subject, and treating immune disorders and inflammatory disorders using such tetrahydroquinoline and related compounds are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.